Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

Live Case Demos: FDA Says More Data Is Needed On Impact On Patient Care

This article was originally published in The Gray Sheet

  • News

Executive Summary

FDA and medical professional societies are considering how best to study the risks of live case demonstrations at physician meetings

You may also be interested in...



Live Case Demos: Guideline Development Is On Track – SCAI’s Dehmer

Development of guidelines for the presentation of live case demonstrations at medical meetings is generating "very positive" feedback from FDA, according to Greg Dehmer, M.D., one of the physicians leading the project

Live Case Demos: Guideline Development Is On Track – SCAI’s Dehmer

Development of guidelines for the presentation of live case demonstrations at medical meetings is generating "very positive" feedback from FDA, according to Greg Dehmer, M.D., one of the physicians leading the project

Guidelines Proposed For Live-Case Demonstrations

Prominent interventional cardiologists plan to create guidelines for live case demonstrations that are broadcast at professional meetings in the face of intensifying scrutiny on the practice

Table

View full table

Topics

Tags:
Medical Device
Latest Headlines

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win

See All
UsernamePublicRestriction

Register

MT027212

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By